CLEOPATRA HOSPITAL COMPANY
CLHO
EGX
Current Price
EGP
EGP (%)
Price Upon Recommendation
7.65 EGP
Target Price from Recommendation
8.00 EGP
+4.57%Holding Period
From 1 to 3 months
Final Recommendation
Buy stock at the current price
Valid Until
May 15, 2025 at 11:59:59 PM
Risk Assessment
Medium
Confidence Score
78.00%
Potential Growth
12.40%
Investment Reason
CLHO is positioned to benefit from Egypt's economic reforms and EGX's liquidity growth, supported by strong sectoral demand and favorable market trends .
Overview
Recent Performance
CLHO surged 8.64% in 30 days, aligning with EGX 30's growth trajectory .
Economic Factors
Egypt's inflation-driven investor shift to equities and EGX's record 2024 performance support bullish sentiment .
Competitive Positioning
Operates in high-growth sectors with limited local competition, enhancing market share potential.
Analysis Summary
CLHO's alignment with EGX's upward momentum, coupled with macroeconomic tailwinds, makes it a strategic short-term play with moderate risk.
Key Points
- 12.4% growth potential aligned with EGX's 2024 record performance
- 8.64% 30-day surge signals strong market sentiment
- Moderate risk with macroeconomic and liquidity tailwinds
- 8.00 EGP target price within 30 days (4.57% return)
